Faricimab

Description

Vabysmo (faricimab) is a prescription injectable solution manufactured by Genentech, Inc., administered via intravitreal injection (into the eye) for treating certain retinal conditions. It contains faricimab at 6 mg per 0.05 mL dose. This information was generated using AI and is provided for informational and research purposes only.

Resources

Name Format Description Link
21 Access the FDA dataset for Faricimab — ANDA 761235 submitted by Mylan Institutional LLC https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761235

Tags

  • fda
  • drug-safety
  • public-health
  • prescription-drugs
  • drug

Topics

Categories